• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MENAQUINONE 4
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION & THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ADROPIN
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • ADDICTION & DOPAMINE
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • ANXIOLYTIC
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BIOMIMETIC HYDROXYAPATITE
      • BMI-1
      • BPA & OBESITY
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CDK5
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DEPERSONALIZATION
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENDOCRINE DISRUPTING CHEMICALS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING & THE BRAIN
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUCOCORTICOID RECEPTOR ACTIVATION
      • GLUTAMATE & BRAIN
      • GLYCATION
      • GUT BRAIN AXIS
      • KLOTHO
      • K OPIOD RECEPTOR & ADDICTION
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HAIR REPIGMENTATION
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERALGESIA
      • HYPERINSULINEMIA
      • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INSULIN OXIDATIVE STRESS
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR & FEAR
      • NON OPIOD ANALGESICS
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • OBESOGENS
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SEX HORMONE BINDING GLOBULIN
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • THROMBOLYTICS (PLANT BASED)
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
      • XENOBIOTICS
      • XENOESTROGEN
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
    February 23, 2021
    DIABETES & CANCER
    February 23, 2021
    1. Female sexual dysfunction-Medical and psychological treatments, Committee 14: Erratum.
    2. I am no male or female or any other, I have no sex: a case report on asexuality.
    3. It’s complicated: the lived experience of female sexual desire: a thesis presented in partial fulfilment of the requirements for the degree of Masters of Science in …
    4. Methodological issues for studying asexuality: Reply to Hinderliter (2009).
    5. Sick, Dead, or Lying: A critical textual analysis of asexuality in popular culture
    6. The nature of the body: anatomizing heterogender in sexual medicine
    7. They Need Labels: Contemporary Institutional and Popular Frameworks for Gender Variance
    8. Women’s sexual desire and arousal disorders: Erratum.
    9. ? Maybe all these random experiences form a cohesive picture?: towards a grounded theory of asexual college students? identity development
    10. … -67: Validation of the “Decreased sexual desire Screener”(DSDS): A brief diagnostic instrument for generalized, acquired hypoactive sexual desire disorder in women
    11. … , AND THE EFFECTIVENESS OF ORGASM CONSISTENCY TRAINING IN THE TREATMENT OF WOMEN REPORTING hypoactive sexual desire.
    12. … : A Randomized, Double-Blind, Placebo-Controlled Study on Efficacy and Safety of Bupropion for the Treatment of hypoactive sexual desire Disorder in Menstruating …
    13. … : The sexual Interest and desire Inventory—Female (SIDI‐F): Item Response Analyses of Data from Women Diagnosed with hypoactive sexual desire Disorder
    14. … and evaluation of the Women’s sexual Interest Diagnostic Interview (WSID): a structured interview to diagnose hypoactive sexual desire disorder (HSDD) in …
    15. … as Measured by the Profile of Female sexual Function, sexual Activity Log, and Personal Distress Scale in Postmenopausal Women with hypoactive sexual desire …
    16. … Decarbonylative Ring Contraction of Quinoxalinediones: Application to the Synthesis of Flibanserin, A Drug for Treating hypoactive sexual desire Disorder in Women …
    17. … desire and the Female sexual Function Index (FSFI): A sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire …
    18. … estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire
    19. … factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner’s hypoactive sexual desire in comparison with …
    20. … HYPOTENSION-AND-SYNCOPE-RELATED ADVERSE EVENTS IN FLIBANSERIN-TREATED PREMENOPAUSAL WOMEN WITH hypoactive sexual desire …
    21. … lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for …
    22. … of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the hypoactive sexual desire Disorder Registry for …
    23. … perspective on clinical trials and end points for female sexual dysfunction, in particular, hypoactive sexual desire disorder: formulating recommendations in an …
    24. … randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire …
    25. … sexual Interest Diagnostic Interview—Short Form (WSID-SF) and a Daily Log of sexual Activities (DLSA) in Postmenopausal Women with hypoactive sexual desire …
    26. … sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire …
    27. … single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised …
    28. “Adopting self-sacrifice”: how Iranian women cope with the sexual problems during the menopausal transition? An exploratory qualitative study
    29. “And now I’m just different, but there’s nothing actually wrong with me”: Asexual marginalization and resistance
    30. “Asexy and we know it”: The Emergence of Asexual Activism as a sexual and Gender Social Movement
    31. “Do I really have to talk about sex?” Encouraging beginning therapists to integrate sexuality into couples therapy
    32. “I am no male or female or any other, I have no sex”: a case report on asexuality
    33. “I Just Go with It”: Negotiating sexual desire Discrepancies for Women in Partnered Relationships
    34. “I want to feel like I used to feel”: a qualitative study of causes of low libido in postmenopausal women
    35. “Informed choice” in a time of too much medicine—no panacea for ethical difficulties
    36. “It takes two to tango”: The relational domain in a cohort of subjects with erectile dysfunction (ED)
    37. “Macho” beliefs moderate the association between negative sexual episodes and activation of incompetence schemas in sexual context, in gay and heterosexual men
    38. “Online” and “at-home” versus traditional models of health care: enhancing access or impeding optimal therapeutics?
    39. “She exploded into a million pieces”: a qualitative and quantitative analysis of orgasms in contemporary romance novels
    40. “The pleasure is better as I’ve gotten older”: sexual health, sexuality, and sexual risk behaviors among older women living with HIV
    41. “This is Torah, and I Must Learn”: Evaluation of Women’s Premarital sexual Education and sexual Satisfaction in the Orthodox Jewish Community.
    42. “Til’I can get my satisfaction”: The Role of sexual Assertiveness in the Relationship between Attachment Orientation and sexual Satisfaction
    43. “Ukuthwala” the sexual-cultural practice with negative effects on the personality of adolescent females in Africa
    44. “Was It Good for You?”: Recasting Catholic sexual Ethics in Light of Women’s sexual Pain Disorders
    45. “What do you mean when you say that you are sexually satisfied?” A mixed methods study
    46. “You Freud, Me Jane?” The Representation of Trauma and Asexuality in Hitchcock’s Marnie
    47. (2009) Self-reported sexual difficulties and their association with depression and other factors among gay men attending high-HIV-caseload general practices in …
    48. @ TOG
    49. 001 Composite Endpoints for Clinical Trials of Women with HSDD: Content, Responder Values, and Remitter Cutoffs
    50. 003 Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and sex Therapy in Pre-and Postmenopausal Women with HSDD
    51. 003 Use of Ospemifene is Associated with Improvements to the Vulva, Vestibule, and Vagina in Women with Genitourinary Syndrome of Menopause (GSM): A …
    52. 004 Safety and Efficacy of High Intensity Focused Ultrasound Treatment for Vagina-3 Months Results
    53. 005 Neuromodulation for Female sexual Dysfunction: Preliminary Pilot Clinical Trial and Patient Interest Survey
    54. 005 The effects of learned sex-disgust associations on female sexual response
    55. 006 Bremelanotide for hypoactive sexual desire Disorder: Integrated Subgroup Analysis According to FSFI Total Score at Screening
    56. 006 Genital and subjective sexual response in women with the Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with a non-surgically created neo-vagina
    57. 007 A Review of Microorganisms Isolated at Salvage or Explant of IPPs: Are We Covering the Correct Bugs?
    58. 007 Use of Neurogenital Testing to Assess for Cauda Equina-Based Sacral and Lumbar Pathologies Potentially Causing Unusual sexual Dysfunctions
    59. 008 Investigating Peripheral Nerve Stimulation as a Treatment for Female sexual Dysfunction using a Preclinical Model
    60. 009 Comparing symptom networks of women with reduced, increased, and stable sexual desire
    61. 009 Retrospective Chart Review of Treatment Outcome Following Low-Intensity Shockwave Therapy for the Treatment of Vestibulodynia with Urogold 100™ MTS
    62. 009 The Fertility Quality of Life (FertiQol) in Chinese Infertile Women: The First Validation Study of Mainland China Ferti-Qol
    63. 01. Prevalence and Risk Factor Profile for Human Papillomavirus Infection Among Uyghur Women in Xinjiang
    64. 010 A Team-based Model of Care for Management of Female sexual Dysfunction
    65. 010 New Drug for Treatment of Female hypoactive sexual desire Disorder-Results of Phase I Clinical Study
    66. 010 The Moderation Effect of Couple-level sexual Satisfaction on Physiological Synchrony During Conversation-based Tasks
    67. 011 Correlation Between Validated Instruments Used in the RECONNECT Studies
    68. 011 Hormonal and Psychosocial Factors Associated to sexual Dysfunctions in Premenopausal Women
    69. 012 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With hypoactive sexual desire Disorder
    70. 012 Eye Dynamics in Patients with Female hypoactive sexual desire Disorder (HSDD): Evidence towards the Top-Down NeuroFunctional Self-Attention-Model (SAM) …
    71. 012 Meta-Analysis of Orgasmic and Overall sexual Function Post Mid-Urethral Sling Surgery
    72. 012 Potential sexual Changes Resulting from LEEP
    73. 013 Associations Between Partner Responses to Low Interest/Arousal and the sexual and Relationship Wellbeing of Women with sexual Interest/Arousal Disorder …
    74. 013 Product Acceptability and Women’s Satisfaction with a Low-dose Solubilized Vaginal Estradiol Softgel Capsule, TX-004H
    75. 013 The Development and Implementation of a Gynecologic Cancer Survivorship Tool
    76. 014 A Phase 2 Program on Female sexual Arousal Disorder and hypoactive sexual desire Disorder: Patient Characteristics and Implications for Diagnosis and …
    77. 014 Do experts for vulva diseases integrate sexual health problems in daily diasease-managment _ self-assessment results at the 10th anniversary of the …
    78. 014 The Investigational Drug Bremelanotide for hypoactive sexual desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
    79. 015 A randomized, wait list-controlled trial suggests that two psychobehavioral interventions are effective for women’s hypoactive sexual desire
    80. 015 Combined Data of Intravaginal Prasterone against Vulvovaginal Atrophy of Menopause
    81. 015 The Impact of Incontinence Procedures at the Time of Vaginal Vault Suspension on Pelvic Pain and Dyspareunia: A Study of sexually Active Women with Post …
    82. 016 Antifibrotic effect of mycophenolate mofetil experimentally induced Peyronie’s Disease with TGF-B
    83. 016 Effectiveness of Medications for Female sexual Dysfunction: Number Needed To Treat (NNT)
    84. 016 Fidgetin-like 2, a Novel Microtubule Regulator, can be Targeted to Promote Nerve Regeneration and Improve Erectile Function after Cavernous Nerve Injury
    85. 016 Vulvoscopic Findings, Patient Reported Outcome (PRO) Measures, and Hormonal Blood Test Values in Menopausal Women with Female sexual Dysfunction Pre …
    86. 017 Bremelanotide (BMT) for hypoactive sexual desire Disorder (HSDD) in the RECONNECT Study: Efficacy Analyses in Study Completers and Responders
    87. 020 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With hypoactive sexual desire Disorder
    88. 020 sexual Distress and Vaginal Symptom Severity in Women Diagnosed with Cancer: Impact of a Vaginal Health Workshop
    89. 021 Do Prior Anti-incontinence Procedures Influence the Success of Artificial Urinary Sphincter Placement?
    90. 021 Flibanserin in Premenopausal Women With hypoactive sexual desire Disorder: Pooled Analysis of Safety From Phase 3, Placebo-Controlled Studies
    91. 022 Predictors and Moderators of sexual Distress in Women with Persistent Genital Arousal Disorder
    92. 022 The Importance of the Developmental Stage of Nonconsensual sexual Experiences in Women’s sexual Adjustment
    93. 023 Reflections of Women Successfully Treated by Flibanserin at a Single Center
    94. 024 Motivations for sexual Intercourse among Women with a History of Childhood sexual Abuse
    95. 025 Direct Determination of Kinetic and Equilibrium Binding of Flibanserin to 5HT1A and 5HT2A Receptors
    96. 025 Lysis of Vulvar Adhesions for Lichen Sclerosus: A Series of 5 Patients
    97. 027 Effect of Alcohol Consumption on the Safety and Tolerability of Flibanserin in Premenopausal Female Volunteers
    98. 027 Preliminary Evidence for a Relationship between Physiological Synchrony and sexual Satisfaction
    99. 028 A Novel Technique for Assessing Vaginal Lubrication
    100. 028 What is the Relation Between Depressive Disorders, Dyspareunia and Other sexual Dysfunctions?
    101. 029 Bremelanotide for hypoactive sexual desire Disorders in the RECONNECT Studies: Analysis of Baseline Free Testosterone Level Quartile Subgroups
    102. 030 Improving Practitioner Knowledge and Clinical Competence in Managing Menopause-Associated Dyspareunia and Female sexual Dysfunction Through …
    103. 035 Patient Reported Outcomes of a Robotic-Assisted Double-Skin Flap Vaginoplasty Technique for Transfeminine Genital Reconstructive Surgery
    104. 036 Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and sex Therapy in Pre-and Postmenopausal Women with HSDD
    105. 037 Open-Label Pilot, Prospective Vulvoscopic Study of Daily Administration of Prasterone Vaginal Inserts in Women with Moderate to Severe Dyspareunia
    106. 038 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies
    107. 039 Effects of sex Steroids on Relaxant/Contractile Pathways in Rat Vagina
    108. 043 Hormonal and Psychosocial Characteristics of Female sexual Dysfunction
    109. 044 FSFI Assessment of Minimally invasive, Fractional CO2 laser treatment for Vulvovaginal Atrophy and Dyspareunia
    110. 045 An Association between the Pain Domain of the Female sexual Function Index (FSFI) and Its Other Domains in Postmenopausal Women with Vulvar and Vaginal …
    111. 046 Cervical Ectropion may be a Cause of Desquamative Inflammatory Vaginitis
    112. 047 Responder Values for Clinical Trials in Female sexual Interest/Arousal Disorder
    113. 048 Evaluation of Common sexual Dysfunctions and Treatment Outcome in a Canadian sexual Medicine Practice
    114. 049 A Double-Blind, Sham Controlled Prospective Pilot Study of Urinary Stress Incontinence and sexual Function in Women After 6 Treatments with HIFEM …
    115. 050 The Effects of Radiofrequency on Female sexual Health
    116. 055 Does Participation in Faith-Based sexual Abstinence Programs Lead to Female sexual Dysfunction
    117. 056 Inflammation May Alter Perception of sexual Arousal and Pleasure in Healthy Women
    118. 057 Mercy sex: How Much Is “Normal” Depends Upon Where You Live
    119. 058 The Impact of Childhood Experiences on Emotional Responses to Partnered Genital Touch in the Laboratory
    120. 062 ColorDoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With sexual Dysfunction: A Gender Perspective
    121. 062 Temperature Controlled Radiofrequency Electrocoagulation for the Treatment of Vulvovaginal Tissue Laxity
    122. 063 Brain Dynamics of Female hypoactive sexual desire Disorder (HSDD)
    123. 063 Flibanserin: Enhanced Pharmacovigilance Study to Assess and Analyze the Risks of Adverse Events of Special Interest
    124. 064 Attitude of Women Nurse Practitioners for Embarrassing Female sexual and Urinary Symptoms in Korea
    125. 064 Brain Dynamics and Predictors of Female hypoactive sexual desire Disorders (HSDD): Two Routes in the Top-Down Neurofunctional Self-Attention Model (SAM) …
    126. 065 Vulvar Findings in GSM Patients Correlate with Severity of Overactive Bladder
    127. 066 Anatomic Sites and Risk Factors for Deep Dyspareunia
    128. 066 Pudendal Neuromodulation for Treatment of Female Orgasmic Disorder
    129. 067 Number Needed to Harm for Treatments of Female sexual Dysfunction
    130. 068 Female sexual Dysfunctions Associated With Male Premature Ejaculation
    131. 069 Hormonal Contraceptive Use and sexual Functioning among Young Women Who Experienced sexual Victimization
    132. 076 Perceptions and Attitudes About Low sexual desire Among Premenopausal Women: Results From a Consumer Survey
    133. 077 On the Initial Treatment Experience of CO2 Fractional Laser for Vulvovaginal Atrophy Symptom in a Single Institute
    134. 078 Exo-clinical Trials to Test Nutraceuticals for sexual Dysfunction
    135. 078 Why Core Emotions Matter: Understanding Subcortical Affective Circuits as Key to Treatment of sexual Disorders
    136. 079 Evaluating the Performance of a Low-cost Mobile Phone Attachable Microscope in Cervical Cytology
    137. 079 Temporal Frequency-Based Typology of Female Orgasm
    138. 079 Vulvar Crohn’s: A Rare Presentation of Crohn’s Disease
    139. 080 Patient Reported Satisfaction Rating After Attending a Multidisciplinary Psychoeducational sexual Wellness Program
    140. 080 Successful Management of Clitorodynia Closed Compartment Syndrome
    141. 080 Women’s Experiences With Bremelanotide Administered, On Demand, for the Treatment of hypoactive sexual desire Disorder
    142. 081 Lorexys Phase 2a Results: Patient’s Global Impression of Change (PGIC)
    143. 082 Nomegestrol Acetate/17beta-estradiol does not Negatively alter the Vascular Resistance of Clitoral Arteries
    144. 083 The Effect of Ristela Supplementation on Female sexual Function in Women Taking Antidepressants: An Open Label Trial
    145. 084 Improvements in Female sexual Function Index (FSFI) Domains Over Time after Flibanserin Treatment in Premenopausal Women with hypoactive sexual desire …
    146. 090 Effects of Bipolar Radiofrequency Treatment on Subjective and Objective Endpoints in Post-Partum Pelvic Floor Disorders
    147. 095 Rethinking the Techno Vagina: A Case Series of Patient Complications Following Vaginal Laser Treatment for Atrophy
    148. 096 Effect of CO2 Fractional Laser on Female Lower Urinary Tract Symptoms by Genitourinary Syndrome of Menopause
    149. 099 Flibanserin vs. Mini-Dose Trazodone for Female sexual Dysfunction? A Challenge
    150. 1 PREVALENCE OF ADULT DISORDERS
    151. 1, 25 dihydroxyvitamin D3 disorganizes actin fibers in human immortalized uterine leiomyoma cells
    152. 1.6 THE SOCIAL ORIGINS OF sexual DEVELOPMENT
    153. 10 Female sexual Dysfunction
    154. 10 Hormone Treatment of Adult Transgender People
    155. 10 Jahre Women’s Health Initiative (WHI): Was haben wir gelernt?
    156. 10 Lust, Romance, Attachment: Do the Side Effects of Serotonin-Enhancing Antidepressants Jeopardize Romantic Love, Marriage, and Fertility?
    157. 10 sexuality and ageing
    158. 10 Things You Aren’t Telling Him
    159. 10 Years in History
    160. 10. Testosteronbehandling till kvinnor
    161. 103 The Effect of Evening Alcohol Consumption and Bedtime Administration of Flibanserin on the Safety of Flibanserin
    162. 104 Flibanserin Subset Analyses and the Androgenics of hypoactive sexual desire Disorder
    163. 105 Preoperative Evaluation
    164. 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
    165. 1075: ATM Sequence Variants are Predictive of the Development of Erectile Dysfunction Among Patients Treated for Prostate Cancer with 125Iodine Brachytherapy
    166. 1076: Smooth Muscle Specific Expression of HSLO Restores Erectile Dysfunction in Diabetic and Aged Rats
    167. 1077: Facilitation of Proceptivity/sexual Motivation in Female Rats by a Serotonin 2A/2C (5-HT2A/2C) Receptors Agonist
    168. 1078: Increase in Proceptivity/sexual Motivation by Melanotan-II (MT-II) in Female Rats
    169. 10Evaluation and management of neurogenic sexual dysfunction
    170. 11 sex Steroids and Mood
    171. 11.4 Two Fundamental Human Motivations: Eating and Mating
    172. 118: THE ASSOCIATION BETWEEN BODY IMAGE AND hypoactive sexual desire DISORDER AMONG REPRODUCTIVE AGE WOMEN: AN IRANIAN …
    173. 12 Asexualities and Disabilities in Constructing sexual Normalcy
    174. 12 How altruism undermines mental health and happiness
    175. 12 sexual Disorders
    176. 12 sexual Disorders among sexual and Gender Minority Populations
    177. 12. M. Workshop: Health and integration of young refugees in Nordic Welfare countries–an equity perspective
    178. 13 ‘More Labels Than a Jam Jar’: The Gendered Dynamics of Diagnosis for Girls and Women with Autism1
    179. 13 Asexuality and Disability
    180. 13 sexual Counseling and Infertility
    181. 13 sexual Response
    182. 13.6 Somatoform, Factitious, and sexual Disorders
    183. 136 Cross-sectional Association between Testosterone and Metabolic Syndrome
    184. 139 Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose, Seven-Way Crossover Study
    185. 14 sexual Distress in Obesity
    186. 14 Testosterone and sexual Function
    187. 14 The Female sexual Dysfunction Debate: Different ‘Problems,’New Drugs–More Pressures?
    188. 146 Conversations With Participants in the RECONNECT Studies About Their Experiences With Bremelanotide for Treatment of hypoactive sexual desire Disorder
    189. 148 Retrospective Study of the Prevalence and Risk Factors of Clitoral Adhesions: Why Women’s Health Providers Should Routinely Examine the Glans Clitoris
    190. 15 Neurocognitive Disorders
    191. 150 BP101 New Molecule for HSDD Treatment-Results of Proof-of-concept Phase 2a Study
    192. 15Chapter
    193. 16 Toward an Asexual Narrative Structure
    194. 16 Treatment of psychosexual problems
    195. 17β-Estradiol and testosterone levels in axillary perspiration of men: Environmental factors, inter-and intra-individual variation
    196. 18 sexual disorders
    197. 18 Vulvovaginal Pain after Breast Cancer Treatment
    198. 19 Female sexual Dysfunction
    199. 19 Female sexual dysfunctions: Future of medical therapy
    200. 19 sexuality in Older Adults
    201. 19 Transgender Health Care and Human Rights
    202. 19. A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF LIBIGEL® FOR …
    203. 193 Bremelanotide for hypoactive sexual desire Disorder: Contraceptive Subgroups Efficacy Analysis
    204. 194 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies
    205. 1Chapter
    206. 2 Inhibition, Lack of Excitation, or Suppression
    207. 2 Seven Leadership Skills for sexuality Educators
    208. 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection
    209. 2010 Sandra Leiblum Presidential Address
    210. 2011 Sandra Leiblum Presidential Address
    211. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
    212. 2016 NEI SYNAPSE—NEW!
    213. 2017-2018 NAMS President
    214. 2018 ICD-10-CM Hospital Professional Edition-E-Book
    215. 2018 ICD-10-CM Physician Professional Edition-E-Book
    216. 2018 ICD-10-CM Standard Edition-E-Book
    217. 2019 FDA TIDES (peptides and oligonucleotides) harvest
    218. 2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
    219. 21 Ejaculatory Disorders
    220. 21 Evolutionary Cognitive Neuroscience
    221. 21 sex and Gender Disorders
    222. 21 The Endocrinology of Female Competition
    223. 213 A Prosthesis-Specific Survey Study: The sexual Quality of Life Benefits of the Inflatable Penile Prosthesis are Generalizable Across Multiple Patient …
    224. 221 A Retrospective Single Center Study of Vulvoscopic Findings, Female sexual Function Index (FSFI) Scores and Hormonal Blood Test Values in Menopausal …
    225. 223 How much Girth is too much Girth? Dimensions of Bestselling Insertive sex Toys to Guide Maximal Phalloplasty Dimensions
    226. 225 Unlocking Female sexual Dysfunction in Muslim Women in America: A Retrospective Look at the Incidence of Vaginismus in this Population
    227. 226 Effect of Flibanserin on Body Weight During Treatment for hypoactive sexual desire Disorder in Premenopausal and Postmenopausal Women
    228. 23 Implications for training, research and service provision
    229. 238 A 10-Year Interval Study to compare the Prevalence and Risk Factors of Female sexual Dysfunction in Korea
    230. 239 sexual and Non-sexual Improvements in Women with HSDD: Personal Experiences with Flibanserin Treatment
    231. 24 DIRECTED MASTURBATION: A TREATMENT OF FEMALE ORGASMIC DISORDER
    232. 24-Hour Urine Comprehensive Hormone Profile Handbook
    233. 240 Alcohol Use and sexual Health Concerns in a sexual Health Clinic
    234. 25 sexual Function, Dysfunction, and Difficulties
    235. 25 years and sex is still hot.
    236. 260 Diabetes and level of fasting blood sugar has no relationship to the development of subsequent penile prosthesis infection in Korean men
    237. 261 Efficacy of metacognitive therapy for hypoactive sexual desire disorder among Iranian couples
    238. 262 Viewing time and penile plethysmography measurement in a group of admitting pedophiles
    239. 27 Mental Health for Asexual Individuals
    240. 27. EVALUATION OF sexual DYSFUNCTION
    241. 28th Annual Meeting of The North American Menopause Society October 11-14, 2017, Philadelphia, PA
    242. 29Arthritis
    243. 2D: 4D digit ratio and its relations to cross-sex and same-sex friendship choices
    244. 2nd Joint Puerto Rican SPED/AACE International Endocrine Update and 28th SPED Post Graduate Diabetes Course: December 8–11, 2005, San Juan, Puerto Rico …
    245. 3 “There’s No Such Thing as a sexual Relationship”
    246. 3-Oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments
    247. 3-oxopiperazinium derivatives as agonists of nerve growth factor receptors and their use as medicaments
    248. 31 Days to Great sex: Love. Friendship. Fun.
    249. 32 Integrative Medicine in Gynecologic Oncology
    250. 341 Mercy sex: How Much Is “Normal”
    251. 376 Vasal Vessels Preserving Microsurgical Vasoepididymostomy
    252. 4 Hypnotherapy and depression
    253. 4.8. G03X Other sex Hormones and Modulators of the Genital System
    254. 40 Psychological abnormalities of male sexual function
    255. 490 HANDBOOK OF CLINICAL INTERVIEWING WITH ADULTS
    256. 4th International Consultation on sexual Medicine June 19–21, 2015 Melia Castilla Hotel, Madrid, Spain
    257. 5 th EURASIAN ANDROLOGY SUMMIT
    258. 5-HT 2A receptor gene polymorphism is associated with food and alcohol intake in obese people
    259. 5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives
    260. 5-HT1A receptor ligands and their therapeutic applications: review of new patents
    261. 5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer
    262. 50+ INCREDIBLE Benefits (And Warnings) for Women When They Take Natural Progesterone (P4)
    263. 54 SENSATE FOCUS FOR sexual DYSFUNCTION
    264. 5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature
    265. 6. sexual Medicine in Finland
    266. 61 SENSATE FOCUS
    267. 62nd Annual Meeting of the American Society for Reproductive Medicine: October 23–25, 2006, New Orleans, LA, USA
    268. 689 Illustrated evaluation of scientific productions of sexual medicine researchers during 2012 till the end of 2016
    269. 690 HIV-related healthcare needs and access barriers for Brazilian transgender and gender diverse people
    270. 691 High serum testosterone is associated with poor pathological outcomes in patients with prostate cancer in Japanese populations
    271. 7 Keys to Lifelong sexual Vitality: The Hippocrates Institute Guide to sex, Health, and Happiness
    272. 7Chapter
    273. 882: Relationship of Self-Diagnosed Premature Ejaculation to Other Indicators of Male sexual Function
    274. 883: The Utility of “Estimated Intra-Vaginal Ejaculatory Latency Time” and “DSM-IV Criteria” in Identifying Premature Ejaculation
    275. 884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159
    276. 885: Prevalence of Female sexual Dysfunction in Germany
    277. 9 Hypnotherapy and sexual problems
    278. 910 THE ROLE OF MAJOR PELVIC GANGLION IN THE NEURAL PATHWAY OF ELECTRICAL STIMULATION OF LESSER SPLANCHNIC NERVE-INDUCED …
    279. 911 SCREENING FOR hypoactive sexual desire DISORDER (HSDD) IN THE UROLOGY OFFICE SETTING
    280. 912 IN-VITRO ANALYSIS OF THE EFFICACY OF PENILE TRACTION ON PEYRONIE’S DISEASE: ASSESSING CELLULAR CHANGES IN PEYRONIE’S PLAQUE IN A …
    281. 9Chapter
    282. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
    283. A 15-item short form of the psychological and interpersonal relationship scales
    284. A 60-year-old woman with sexual difficulties
    285. A baseline-controlled, open-label, flexible dose-escalation study to assess the safety and efficacy of sildenafil citrate (Viagra®) in patients with erectile …
    286. A Bedroom of One’s Own: Morality and sexual Privacy after Lawrence v. Texas
    287. A behavioral systems approach to romantic love relationships: Attachment, caregiving, and sex
    288. A Bibliography of 34 Counter-Narrative Sources Prepared for the FDA ‘Patient-Focused Drug Development Public Meeting and Scientific workshop on Female …
    289. A Bibliography of Randomized Controlled Experiments in Social Work (1949–2013) Solvitur Ambulando
    290. A biopsychosocial approach to women’s sexual function and dysfunction at midlife: A narrative review
    291. A Brief Description of the Disorders
    292. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer
    293. A Brief Version of the sexual Interest and desire Inventory–Female With 4 Core Items
    294. A Canadian Cost-Utility Analysis of two Trabecular Micro-Bypass Stents in Patients with Mild-to-Moderate Open-Angle Glaucoma
    295. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder
    296. A Case of desire Disparity
    297. A case of enhancing sexual confidence: both the client and the therapist are the experts
    298. A case of inguinal endometriosis in the absence of previous gynecologic surgery
    299. A case of premature ejaculation: too little, too late?
    300. A case series of androgen use in breast cancer survivors with sexual dysfunction
    301. A Case with Male Erectile Disorder and hypoactive sexual desire Disorder Treated by Psychotherapy Using Hypnosis
    302. A clinical update on female androgen insufficiency—testosterone testing and treatment in women presenting with low sexual desire
    303. A clinician’s guide to systemic sex therapy
    304. A clinician’s guide to systemic sex therapy
    305. A Clinician’s Guide to Systemic sex Therapy
    306. A cognitive-behavioral approach to sex therapy
    307. A cognitive-motivational approach to understanding gendered sexual response: The role of attentional mechanisms
    308. A combined-constructionist therapeutic approach to couples experiencing erectile dysfunction: Part II
    309. A commentary on sexual well-being, happiness and satisfaction in women: The case for a new conceptual paradigm
    310. A commentary on transdermal drug delivery systems in clinical trials
    311. A Comparative study of sexual Dysfunction in Remitted Patients Taking Antipsychotics Versus Antidepressants
    312. A comparative study of the sexual functioning of women with primary headache in India
    313. A comparative study using orgasm consistency training in the treatment of women reporting hypoactive sexual desire
    314. A Comparison between Males/Females and Divorcing ones on sexual Functioning in Isfahan
    315. A comparison of 19th century and current attitudes to female sexuality
    316. A comparison of DSM‐IV‐TR and DSM‐5 definitions for sexual dysfunctions: Critiques and challenges
    317. A comparison of five-factor personality dimensions in males with sexual dysfunction and males with paraphilia
    318. A comparison of medical comorbidities, psychosocial, and sexual well-being in an online cross-sectional sample of women experiencing persistent genital arousal …
    319. A comparison of mindfulness-based cognitive therapy vs cognitive behavioral therapy for the treatment of provoked vestibulodynia in a hospital clinic setting
    320. A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment
    321. A comparison of sexual function in primiparous and multiparous women
    322. A Comparison of Spontaneous and Responsive Models of sexual desire in Women Who Meet Screened Criteria for Female sexual Interest/Arousal Disorder
    323. A Comparison of the sexual Well-Being of New Parents With Community Couples
    324. A COMPREHENSIVE GUIDE TO UNDERSTANDING LESBIAN sexual HEALTH: REACHING A VULNERABLE POPULATION
    325. A comprehensive review of erectile dysfunction in men with diabetes
    326. A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients
    327. A Comprehensive Review of the Phytochemical, Pharmacological, and Toxicological Properties of Tribulus terrestris L.
    328. A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE …
    329. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment—a systematic review
    330. A critical discourse analysis of herbal sexual medicine websites marketing to women: a thesis presented in partial fulfilment of the requirements for the degree of …
    331. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease
    332. A critical examination of popular assumptions about the benefits and outcomes of monogamous relationships
    333. A critical examination of the relationship between vaginal orgasm consistency and measures of psychological and sexual functioning and sexual concordance in …
    334. A critical feminist analysis of madness
    335. A critical review of repurposing apomorphine for smoking cessation
    336. A cross-cultural study of midlife relational and sexual health: Comparing Ukraine to the US and Turkey
    337. A cross-national examination of sexual desire: The roles of ‘gendered cultural scripts’ and ‘sexual pleasure’in predicting heterosexual women’s desire for sex
    338. A cross-sectional study of female sexual function and dysfunction during pregnancy
    339. A Culturally Grounded Approach to Psychotherapy with Chaldean Americans
    340. A current perspective into young female sex hormone replacement: a review
    341. A Current Study on Benzimidazole Derivatives
    342. A Delicate Balance
    343. A Descriptive Analysis of sexual Problems in Long-Term Heterosexual Relationships
    344. A diagnosis of denial: How mental health classification systems have struggled to recognise family violence as a serious risk factor in the development of mental …
    345. A discordant monozygotic twin approach to testing environmental influences on sexual dysfunction in women
    346. A discursive look at the friend/partner distinction: Implications for asexual people
    347. A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: perinatal prediction of randomized clinical trials
    348. A double blind placebo controlled study of granisetron in antidepressant induced sexual dysfunction
    349. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido
    350. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women
    351. A double-blind, randomised-placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil …
    352. A dvances in cancer screening and treatments have resulted in an increase
    353. A Dyadic Examination of Female Partners’ Accommodation of Male Service Members’ Posttraumatic Stress Symptoms and Caregiver Burden as Correlates of Military …
    354. A dyadic longitudinal study of child maltreatment and sexual well-being in adult couples: the buffering effect of a satisfying relationship
    355. A dyadic perspective on childhood maltreatment for women with provoked vestibulodynia and their partners: Associations with pain and sexual and psychosocial …
    356. A facile route of synthesis for making Flibanserin
    357. A Feminist Contestation of Ableist Assumptions: Implications for Biomedical Ethics, Disability Theory, and Phenomenology
    358. A feminist perspective on sexuality and body image in females with colorectal cancer: an integrative review
    359. A feminist revision of contemporary sex therapy
    360. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions
    361. A further examination of Levine’s model of sexual desire
    362. A general look at female orgasm and anorgasmia
    363. A grounded theory study of the psychological impact of taking part in sexual actions which are accepted versus those which are desired
    364. A group therapy format for the simultaneous treatment of marital and sexual dysfunctions: A case illustration
    365. A history of erotic philosophy
    366. A holistic treatment approach to male erectile disorder
    367. A journey into the dangers of orthodoxy from the former director of the Freud Archives
    368. A Journey Through Psyche’s sexual Energy
    369. A language and methodology for studying the hierarchies in the DSMs
    370. A large-scale test of the replicability and generalizability of survey measures in close relationship and sexuality science
    371. A lexicon of lunacy
    372. A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction
    373. A literature review on the relationship between infertility and sexual dysfunction: does fun end with baby making?
    374. A literature review on vulvodynia and distress
    375. A Longitudinal Examination: The Relationship between sexuality and Mental Health-Related Quality of Life for Breast Cancer Survivors
    376. A longitudinal study of problems in sexual functioning and related sexual distress among middle to late adolescents
    377. A longitudinal study of sexual function in women with newly diagnosed inflammatory bowel disease
    378. A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause
    379. A MedFT-informed sex therapy for treating sexual problems associated with chronic illness
    380. A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women
    381. A mindfulness psychoeducational group intervention targeting sexual adjustment for women with multiple sclerosis and spinal cord injury: a pilot study
    382. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women
    383. A Mixed Methods Analysis of the Concept of Female sexual Health
    384. A Mixed-Methods Inquiry into the Intimate Practices of Partnered Mature Students and Influences on Relationship, sexual, and School Satisfaction.
    385. A model for the capacity building of Somalia midwifery educators through a blended, web-based Master Programme
    386. A model for the management of female sexual dysfunctions
    387. A model of female sexual desire: Internalized working models of parent–child relationships and sexual body self-representations
    388. A model of physician intentions toward initiating a dialogue about sexual health with women
    389. A more radical proposal: Dyspareunia is not a mental disorder
    390. A multidisciplinary approach to sexual behavior profiles: The sex360 model
    391. A multidisciplinary approach to sexual dysfunction in female athletes
    392. A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care
    393. A multivariate analysis of the factors that influence the modification of sexual desire in oral hormonal contraceptive (OC) users
    394. A mystery wrapped in an enigma–asexuality: a virtual discussion
    395. A nationwide study on breast cancer risk in postmenopausal women using hormone therapy in Finland
    396. A neglected issue: The sexual side-effects of current treatments for breast cancer.
    397. A neutral odor may become a sexual incentive through classical conditioning in male rats
    398. A new deal on disease definition
    399. A new editorial structure for sexual and Marital Therapy
    400. A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence
    401. A new glucose monitoring option
    402. A new instrument to measure sexual competence and interaction competence in youth: psychometric properties in female adolescents
    403. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence sexual Questionnaire, IUGA-Revised …
    404. A new non-pharmacological vacuum therapy for female sexual dysfunction
    405. A new view of women’s sexual problems: Why new? Why now?
    406. A novel collaborative protocol for successful management of penile pain mediated by radiculitis of sacral spinal nerve roots from Tarlov cysts
    407. A novel design and facile synthesis of nature inspired poly (dopamine-Cr3+) nanocubes decorated reduced graphene oxide for electrochemical sensing of flibanserin
    408. A Novel LC-ESI-MS/MS Method for the Quantification of Flibanserin in Bulk and Pharmaceutical Formulations
    409. A Panoramic View
    410. A Phase 2a Multicenter, Double‐Blind, Placebo‐Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP‐866,087 (a High‐Affinity Mu …
    411. A phenomenological defense of sexual pharmakotherapy
    412. A phenomenological inquiry into the lived experience of low sexual desire in women: Implications for clinical practice
    413. A phenomenological study of women in same-sex relationships who were previously married to men
    414. A phenomenology of sexual experiencing
    415. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy
    416. A pilot study of a topical intervention for treatment of female sexual dysfunction
    417. A pilot study of eight-session mindfulness-based cognitive therapy adapted for women’s sexual interest/arousal disorder
    418. A pilot study of soft gel technology: a new vaginal device to improve the symptomatology of vulvovaginal atrophy in post-partum, menopause and in patients …
    419. A Pilot Study on Evaluation of Standardized Ayurveda formulation Ashwagandhadi lehya as Aphrodisiac and in treatment of Oligospermia
    420. A place for sexual dysfunctions in an empirical taxonomy of psychopathology
    421. A place of androgen deficiency in a clinical portrait of the modern urological patient
    422. A Placebo-Controlled, Randomized, Double-Blind, Three Period, Three-Way Crossover Study on the Hemodynamic and Pharmacokinetic Interactions of …
    423. A PLISSIT-model intervention in people with type 2 diabetes with sexual problems: results from a cluster-randomized controlled trial in primary care
    424. A population-based epidemiologic study of female sexual dysfunction risk in Mainland China: prevalence and predictors
    425. A PORTFOLIO OF STUDY, PRACTICE AND RESEARCH
    426. A positive approach toward asexuality: Some first steps, but still a long way to go
    427. A potential aphrodisiac for female macaques
    428. A practical approach to desire problems
    429. A practical approach to managing hypoactive sexual desire disorder in women with diabetes
    430. A Practical Cognitive-Behavioral Treatment Approach
    431. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada
    432. A practical guide to gynecologic and reproductive health in women undergoing hematopoietic stem cell transplant
    433. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial
    434. A practitioner’s toolkit for managing the menopause
    435. A preclinical model of menopause: the ovariectomized female rat
    436. A preliminary investigation of affective and cognitive response to erotic stimulation in men before and after sex therapy
    437. A preliminary investigation on the evaluation of psychopathologies in a group of ex-pet and ex-performer chimpanzees (Pan troglodytes): A rating approach based on …
    438. A preliminary study of women with persistent sexual arousal syndrome
    439. A program for the treatment of inhibited sexual desire in males.
    440. A Prospective Clinical Observational Study on Assessment of Risk Factors, Diagnosis and Prescribing Patterns of Medications for Migraine
    441. A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
    442. A prospective study of outcomes after hysterectomy in mid-aged Australian-born women
    443. A prospective study of psychiatric aspects of early HIV disease in women
    444. A Psychiatric Diagnosis Primer: An Easy Guide to Identifying Psychiatric Illness
    445. A psychiatrist’s guide to sexual dysfunction in women
    446. A psychobiosocial model for assessment, treatment, and relapse prevention for female sexual interest/arousal disorder
    447. A psychophysiological investigation of sexual arousal in women with lifelong vaginismus
    448. A psychophysiological perspective on vulvodynia.
    449. A qualitative comparison of young women’s maintained versus decreased sexual desire in longer-term relationships
    450. A qualitative exploration of factors that affect sexual desire among men aged 30 to 65 in long-term relationships
    451. A qualitative exploration of men’s experiences of sexual desire in heterosexual long-term relationships
    452. A Qualitative Exploration of the Distress and Consequences Experienced by Women with Low sexual desire and their Partners in Long-Term Relationships
    453. A qualitative exploration of the distress experienced by long-term heterosexual couples when women have low sexual desire
    454. A qualitative exploration of the meaning and experience of sexual desire among partnered women
    455. A qualitative investigation of male partners’ experience of relationships with women suffering from vaginismus
    456. A randomized clinical trial for women with vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy
    457. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual
    458. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized …
    459. A randomized controlled intervention trial of a sexual health approach to long-term HIV risk reduction for men who have sex with men: effects of the intervention on …
    460. A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors
    461. A Randomized Study Comparing Video-Based Mindfulness-Based Cognitive Therapy With Video-Based Traditional Cognitive Behavioral Therapy in a Sample of …
    462. A randomized trial of low-cost mesh in groin hernia repair
    463. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
    464. A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women
    465. A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women
    466. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal …
    467. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on sexual memory consolidation in women
    468. A randomized, waiting-list-controlled study shows that brief, mindfulness-based psychological interventions are effective for treatment of women’s low sexual desire
    469. A rapid and sensitive stability-indicating green RP-HPTLC method for the quantitation of flibanserin compared to green NP-HPTLC method: Validation studies and …
    470. A rapid and sensitive UPLC-MS/MS method for the determination of flibanserin in rat plasma: application to a pharmacokinetic study
    471. A rare cause of difficulty with sexual intercourse: large retroperitoneal leiomyoma
    472. A rare cause of infertility: A late complication of female genital mutilation
    473. A reasoned action approach to understand vaccination intention among healthcare professions students
    474. A reflexive action research project to investigate the development of an educational public health website with an integrated online advice service
    475. A reintroduction to clinical sexuality
    476. A relational-feminist psychodynamic approach to sexual desire
    477. A replication study of obsessional followers and offenders with mental disorders
    478. A Rethinking of Gray Asexuality: What do we Learn from an Undefinable Identity?
    479. A Review of “Clinical Handbook of Couple Therapy” Alan S. Gurman (Ed).(2008). New York: Guilford Press, 736 pp., $90.00
    480. A review of affecting factors on sexual satisfaction in women
    481. A review of antidepressant therapy in primary care: current practices and future directions
    482. A review of anxiety and sexual arousal in human sexual dysfunction
    483. A review of breast cancer survivorship issues from survivors’ perspectives
    484. A review of experimental research on anxiety and sexual arousal: Implications for the treatment of sexual dysfunction using cognitive behavioral therapy
    485. A review of infrared thermography as applied to human sexual psychophysiology
    486. A review of male and female sexual function following colorectal surgery
    487. A review of mindfulness-based sex therapy interventions for sexual desire and arousal difficulties: From research to practice
    488. A review of patient-reported outcome labeling in the United States (2011–2015)
    489. A review of recent innovations in the treatment of low sexual desire
    490. A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris
    491. A review of treatment-related outcomes in female partners of men with Peyronie’s disease—an Opportunity for improved Assessment
    492. A Review of: “Principles and Practice of sex Therapy. Fourth Edition” edited by Sandra R. Leiblum, The Guilford Press, New York, New York; 2007; ISBN 978-1-59385 …
    493. A Review of” Systemic sex Therapy”
    494. A Review on the role of Tribulus terrestris in the reproductive biology
    495. A role for melanocortin agonists in treating male and female sexual dysfunction
    496. A rose by any other name: Should dyspareunia be reclassified?
    497. A s an extension of their study demonstrating that topira
    498. A Selection of Notable Papers from the Past 25 Years
    499. A selective role for right insula—basal ganglia circuits in appetitive stimulus processing
    500. A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study
    501. A sex-specific dose-response curve for testosterone: could excessive testosterone limit sexual interaction in women?
    502. A sexual masquerade: the performance of desire and femininity in a Fifty Shades of Grey era: a thesis presented in partial fulfilment of the requirements for the degree …
    503. A sexual medicine health care model and nurse practitioner role.
    504. A short review on potential activities of benzimidazole derivatives
    505. A Short Term Cognitive and Behavorial Treatment Approach to sexual desire Phase Dysfunction
    506. A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes
    507. A skeptical view of desire norms and disorders promotes clinical success
    508. A slightly different idea
    509. A socio-cognitive approach of human sexual desire
    510. A Sociological Perspective on Impulsivity: Some Cautionary
    511. A specific nursing educational program in patients with Cushing’s syndrome
    512. A Standard for Terminology in Chronic Pelvic Pain Syndromes (CPPS): A Report from the Working Group of the International Continence Society …
    513. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society
    514. A standardized diagnostic interview for hypoactive sexual desire disorder in women: standard operating procedure (SOP Part 2)
    515. A stepped-care approach to symptomatic endometriosis management: a participatory research initiative
    516. A streetcar named “Derousal”? A psychophysiological examination of the desire–arousal distinction in sexually functional and dysfunctional women
    517. A strong pelvic floor is associated with higher rates of sexual activity in women with pelvic floor disorders
    518. A structural equation modeling analysis of the relationships between depression, anxiety, and sexual problems over time
    519. A study assessing the quality of life related to voiding symptoms and sexual functions in menopausal women
    520. A Study of Correlation of sexual Dysfunction with Serum Uric Acid Level in Alcohol Dependent Individuals
    521. A study of marriage and family counselling services of Pentecostal and Charismatic churches in Cape Coast metropolis
    522. A study of possible associations between single nucleotide polymorphisms in the estrogen receptor 2 gene and female sexual desire
    523. A study of prevalence of sexual dysfunction & assessment of related factors in women referring to mother-baby clinics in Tehran
    524. A Study of sexual Dysfunction among Male Alcohol Dependent Patients.
    525. A Study of sexual Dysfunction in a Sample of Medicated and non Medicated Egyptian Female Patients with Schizophrenia
    526. A study of sexual related determinants and marital quality among married couple in Malaysia
    527. A STUDY OF THE CONNECTION BETWEEN INSECURE ATTACHMENT
    528. A study of the Libidinal impulses and its Management in adolescents
    529. A study of various factors associated with sexual dysfunction in males with type 2 diabetes mellitus
    530. A Study on the Development of
    531. A STUDY ON THE FACTORS THAT INFLUENCE ASCHENBACH’S sexual ORIENTATION IN MANN’S DEATH IN VENICE
    532. A study protocol of vaginal laser therapy in gynecological cancer survivors
    533. A Survey of Biological, Psychological, Sociological, and Cultural Factors
    534. A survey of Relate psychosexual therapy clients, January to March 2002
    535. A survey of urban middle-aged women’s sexual function and sexual distress
    536. A Swiss longitudinal study of the prevalence of, and overlap between, sexual problems in men and women aged 20 to 50 years old
    537. A symptomatic approach to understanding women’s health experiences: a cross-cultural comparison of women aged 20 to 70 years
    538. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal …
    539. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal …
    540. A systematic review of sexual distress measures
    541. A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men
    542. A systematic review of the literature on female sexual dysfunction prevalence and predictors
    543. A systemic approach to sensate focus
    544. A Systemic Approach to sex Therapy
    545. A test of three hypotheses concerning attributions toward female promiscuity
    546. A Textual Analysis of Online Asexual Representation and Visibility on Reddit
    547. A theory of love and sexual desire
    548. A Traditional Masters and Johnson behavioral approach to sex therapy
    549. A Transdiagnostic Approach to sexual Distress and sexual Pleasure: A Preliminary Mediation Study with Repetitive Negative Thinking
    550. A Turkish study of prevalence and risk factors for low sexual function in women.
    551. A Typology of Women with Low sexual desire
    552. A unique patient presenting with concomitant Klinefelter syndrome, Alport syndrome, and craniopharyngioma
    553. A validated UPLC–MS/MS method for flibanserin in plasma and its pharmacokinetic interaction with bosentan in rats
    554. A Woman Complaining of Lack of sexual desire: sexological Counseling
    555. A-Identity Politics: Asexual Exceptionalism, Precarity, and Activism
    556. A172 Abstracts
    557. A182 Abstracts
    558. AB029. Meeting sexual health requirements in menopause
    559. AB033. Comparing male and female sexual arousal, utilizing fMRI: a theoretical perspective
    560. Abdullah A, Wolfe R, Mannan H, Stoelwinder JU, Stevenson
    561. Aberrant baseline brain activity in psychogenic erectile dysfunction patients: a resting state fMRI study
    562. Aberrant insula-centered functional connectivity in psychogenic erectile dysfunction patients: a resting-state fMRI study
    563. Aberrant topological patterns of structural cortical networks in psychogenic erectile dysfunction
    564. Abnormal degree centrality in lifelong premature ejaculation patients: an fMRI study
    565. Abnormal desire or normal for females? Addressing women’s disinterest in sex
    566. Abnormal Libido
    567. Abnormal psychology
    568. Abnormal sexuality in Parkinson’s disease: fact or fancy?
    569. Abnormalities of sexual function and interest: origins and interventions
    570. About Ochsner
    571. About Ochsner
    572. Above and beyond short-term mating, long-term mating is uniquely tied to human personality
    573. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N …
    574. ABSTR ACT PRESENTATIONS
    575. Abstracts 32nd Annual Meeting of the North American Society for Psychosocial Obstetrics and Gynecology
    576. Abstracts from the 2017 American College of Medical Toxicology (ACMT) annual scientific meeting
    577. Abstracts from the XVII World Congress of sexology
    578. Abstracts from Women’s Health 2012: The 20th Annual CongressMarch 16–18, 2012 Washington, DC
    579. Abstracts from Women’s Health 2016: The 24th Annual Congress April 14–17, 2016 Washington, DC
    580. Abstracts from Women’s Health 2017: The 25th Annual Congress April 28–30, 2017 Washington, DC
    581. Abstracts from Women’s Health 2018: Translating Research into Clinical Practice May 4–6, 2018 Washington, DC
    582. Abstracts fromWomen’s Health 2013: The 21st Annual CongressMarch 22–24, 2013Washington, DC
    583. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy
    584. Accessing health care on the asexual spectrum: A feminist analysis of patient-practitioner relationships and compulsory sexuality in medical discourse
    585. Accounts of the impact of erectile dysfunction on heterosexual couples from men seeking erectogenic treatment and their partners
    586. Accreditation rules safeguard continuing medical education from commercial influence
    587. Ace and aro: understanding differences in romantic attractions among persons identifying as asexual
    588. ACE angiotensin-converting enzyme AED anti-epileptic drug AFP α-fetoprotein ALT alanine transaminase
    589. Ace: What Asexuality Reveals About desire, Society, and the Meaning of sex
    590. Acetylcholinesterase inhibitory and antioxidant activities of Ferula caspica and F. halophila extracts
    591. Achievement of and Failure to Achieve Orgasm in sexual Relationship: Exploring Iranian Women’s Experiences
    592. Acknowledging female sexual dysfunction in women with cancer.
    593. ACOG guideline on sexual dysfunction in women
    594. ACR, ACRUX LIMITED
    595. Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center
    596. ACT for Gender Identity: The Comprehensive Guide
    597. Activation of sensory cortex by imagined genital stimulation: an fMRI analysis
    598. Acupuncture and female sexual dysfunction: a time-series study of symptom relief
    599. Acupuncture in premenopausal women with hypoactive sexual desire disorder: a prospective cohort pilot study
    600. Acupuncture in premenopausal women with hypoactive sexual desire disorder: a prospective cohort study
    601. Acute Aortic Dissection in a Postmenopausal Female in the Setting of Parenteral Testosterone, Estradiol, and Progesterone Therapy
    602. Acute Cannabis Intoxication and the Brain’s Response to Visual Erotica: An Fmri Study
    603. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women
    604. Acute exercise improves physical sexual arousal in women taking antidepressants
    605. Acute withdrawal but not long-term withdrawal from methamphetamine affects sexual behavior in female rats
    606. Adaptación, validación y fiabilidad del Cuestionario de funcionamiento sexual del Hospital General de Massachusetts en una muestra colombiana y equivalencia …
    607. Adaptation and validation of the sexual Assertiveness Scale (SAS) in a sample of male drug users
    608. Adaptation, validation and reliability of the Massachusetts General Hospital-sexual Functioning Questionnaire in a Colombian sample and factorial …
    609. Adapting a couple-based intimacy enhancement intervention to breast cancer: A developmental study.
    610. Addiction is not just a brain disease
    611. Addiction or compulsion: politics or illness?
    612. Adding insult to injury: The classification of dyspareunia as a sexual dysfunction in the DSM
    613. Addressing both genders in sexual medicine diagnosis and treatment
    614. Addressing sexual Dysfunction After Childhood sexual Abuse: A Clinical Approach from an Attachment Perspective
    615. Addressing sexual dysfunction in colorectal cancer survivorship care
    616. Addressing sexuality with clients: A manual for therapists in training
    617. Addressing the sexual function of women during first six month after delivery: Aquasi-experimental study
    618. Addressing the sexual problems of Iranian women in a primary health care setting: A quasi-experimental study
    619. Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women
    620. Adiposity, chronic inflammation, and the prepubertal decline of sex hormone binding globulin in children: evidence for associations with the timing of puberty …
    621. Adjudicating sex crimes as mental disease
    622. Adjuvant Rosa damascena has a small effect on SSRI-induced sexual dysfunction in female patients suffering from MDD
    623. Adolescence as a risk factor for maternal and perinatal complications in Cali, Colombia, 2002-2007: a cross-sectional study
    624. Adolescent and pediatric
    625. Adolescent stalking: A review
    626. Adrenal androgens and aging
    627. Adrenal androgens impact on neurosteroids
    628. Adrenal cortex
    629. Adrenal cortex
    630. Adrenal cortex
    631. Adrenal disorders, female androgen deficiency, hirsutism, and endocrine hypertension
    632. Adrenocortical effects of oral estrogens and soy isoflavones in female monkeys
    633. Adult hypothyroidism
    634. Adult-onset hypogonadism
    635. Adulteration of herbal sexual enhancers and slimmers: The wish for better sexual well-being and perfect body can be risky
    636. Adulteration of Synthetic Substances in Dietary Supplements
    637. Advanced symptom management in multiple sclerosis
    638. Advances in hormone replacement therapy: making the menopause manageable
    639. Advances in neurosteroids: role in clinical practice
    640. Advances in pharmacotherapy for treating female sexual dysfunction
    641. Advances in the treatment of vulvovaginal atrophy
    642. Advancing sexual Health for the Christian Client: Data and Dogma
    643. Advise Against Flibanserin
    644. Advocating for a transdisciplinary perspective in sexual medicine
    645. Aetiology, diagnostic algorithms and prognosis of female sexual dysfunction
    646. Affective and Autonomic Responses to Erotic Images among Young Women with and without sexual Difficulties
    647. Affective and autonomic responses to erotic images: evidence of disgust-based mechanisms in female sexual interest/arousal disorder
    648. Affirmative practice and alternative sexual orientations: Helping clients navigate the coming out process
    649. African American women living with HIV/AIDS: Mental health issues
    650. African and European HIV-positive women: psychological and psychosocial differences
    651. Aftershock: The lived experience of chemotherapy, induced menopause for breast cancer survivors and its impact on their sexuality
    652. Age and Decline of sexuality
    653. Age and gender considerations in psychiatric diagnosis: A research agenda for DSM-V
    654. Age and psychologic disorders: variables associated to post-infarction sexual dysfunction
    655. Age and sex
    656. Age-related changes in the male reproductive system
    657. Age-related differences in health complaints: the Hilo women’s health study
    658. Age-related prevalence rates of sexual difficulties, sexual dysfunctions and sexual distress in heterosexual men: results from an online survey in Flanders
    659. Age‐related prevalence rates of sexual difficulties, sexual dysfunctions, and sexual distress in heterosexual women: Results from an online survey in Flanders
    660. Age, gender, depression, and sexual dysfunction in Taiwan
    661. Ageing, infertility and gynaecological conditions: how do they affect sexual function?
    662. Ageratum conyzoides L. inhibits 5‐alpha‐reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise …
    663. Aging and erectile function
    664. Aging and male sexuality
    665. Aging and pathogenesis of erectile dysfunction
    666. Aging and sexual response in the laboratory in patients with erectile dysfunction
    667. Aging and sexuality
    668. Aging is a powerful predictor of sexual dysfunction. Age-related changes in sexual behavior in men, with attention
    669. Aging, androgens, and female sexual desire: Can we restore what time takes away?
    670. Agreement of self-reported and genital measures of sexual arousal in men and women: A meta-analysis
    671. AIDS. Pediatr Pathol. 1988; 8: 417–421. Degano B, Guillaume M, Savale L, Montani D, et al. HIV-associated pul-monary arterial hypertension: survival and prognostic …
    672. Alcohol and drug effects on sexual response: Human experimental and clinical studies
    673. Alcohol and sexual health behavior:“What we know and how we know it”
    674. Alessandra Graziottin
    675. Alexithymia, negative emotions, and sexual behavior in heterosexual university students from Italy
    676. ali zobozdravniški poslanci v skupščini
    677. All his sexless patients: Persons with mental disabilities and the competence to have sex
    678. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial
    679. Allosteric ligands for G protein‐coupled receptors: A novel strategy with attractive therapeutic opportunities
    680. Alterations in grip strength during male sexual arousal
    681. Alterations in sexual function
    682. Alterations of sexual function in women with cancer
    683. Alterations of the Monoaminergic Systems by Sustained Triple Reuptake Inhibition
    684. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation
    685. Altered states of consciousness are related to higher sexual responsiveness
    686. Alternative formats
    687. Alternative therapies for male and female sexual dysfunction
    688. Alternative treatment modalities for the hypogonadal patient
    689. Alters and Schiff Essential Concepts for Healthy Living
    690. Am I a father? A husband’s miscarriage
    691. Amalgamation of stress degradation and metabolite profiling in rat urine and feces for characterization of oxidative metabolites of flibanserin using UHPLC-Q-TOF-MS …
    692. Ambulatory blood pressure
    693. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience
    694. Amelioration of sexual adverse effects in the early breast cancer patient
    695. Amenorrhoea, oligomenorrhoea and hypothalamic–pituitary dysfunction
    696. American Association for Cancer Research And American College of Obstetricians and Gynecologists
    697. American sexual histories
    698. Amit Garg A Mechanism Based Population Pharmacokinetic-Pharmacodynamic Model for Epoetin Alfa and Darbepoetin Alfa in Chronic Kidney Disease …
    699. Amygdala–frontal interactions and reward expectancy
    700. An Analysis of the Development and Validation of the Decreased sexual desire Screener for the Diagnosis of hypoactive sexual desire Disorder
    701. An analysis of the MMPI-2 profiles of individuals entering treatment at a sexual addiction treatment facility
    702. An Analysis of the Theoretical Origins and Persistance of Asexuality in Humans
    703. An approach to sexual dysfunction in menopausal women
    704. AN ARCHETYPAL AND INNER CAST OF CHARACTERS APPROACH TO sex THERAPY WITH WOMEN WHO HAVE LOW sexual desire
    705. An assessment of rates of psychiatric morbidity and functioning in HIV disease
    706. An Ayurvedic personalized prophylactic protocol in COVID-19
    707. An easy method to define the cervical borders during postpartum hysterectomy
    708. An epidemiological study of sexual disorders in south Indian rural population
    709. An Evaluation and Comparison of Methods Assessing Erectile Dysfunction
    710. An Evaluation of sexual Victimization History and Psychological Adjustment on sexual Health in Women
    711. An evaluation of the quality of life and sexual status functions of females with urinary incontinence
    712. An Evaluation of the Readability of Drug Trials Snapshots
    713. An evaluation of the relationship between body image and sexual avoidance
    714. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction
    715. An evidence‐based unified definition of lifelong and acquired premature ejaculation: Report of the second International Society for sexual Medicine Ad Hoc …
    716. An evolutionary functional analysis of the hormonal predictors of women’s sexual motivation
    717. An Examination of Disgust, Its Measures, and Gender Differences in the Experience of Disgust Sensitivity
    718. An Examination of sexual Fantasy with Specific Emphasis on both Fluid and Constant Variables: The Effect of Gender, Age, sexual Orientation, Ethnicity …
    719. An Examination of sexuality in Women with an Elevated Risk for Breast Cancer Development
    720. An Examination Of The Effect Of Professional License Type And Gender On The Self-efficacy And Comfort Level Of Counseling Skills In Addressing sexual Issues …
    721. An Examination of the Negative Impact of the Western Cultural sex Paradigm on Female sexuality
    722. An Examination of the Relationship between Authenticity and Female sexual Dysfunction
    723. An examination of the sexual double standard pertaining to masturbation and the impact of assumed motives
    724. An Experimental Examination of Automatic Interpretation Biases in Major Depression
    725. An experimental investigation of the impact of body image on subjective sexual arousal among sexually dysfunctional women
    726. An exploratory study of the relationship between second toe length and androgen-linked behaviors.
    727. An exploratory study on the central nervous correlates of sexual excitation and sexual inhibition
    728. An immunological insight into premature ovarian failure (POF)
    729. An injury-induced cell model of early uterine fibroid development
    730. An intake interview and assessment instrument for adults presenting with a history of childhood sexual abuse
    731. An integrated model to assess and treat compulsive sexual behaviour disorder
    732. An integrative cognitive-behavioral approach to understanding, assessing, and treating female sexual dysfunction
    733. An integrative medicine approach to the treatment of HSDD: introducing the HURT Model™
    734. An integrative model for treatment of sexual desire disorders: An update of the masters and Johnson institute approach
    735. An integrative theoretical framework for understanding sexual motivation, arousal, and behavior
    736. An interactional approach to sexual dysfunctions
    737. An Internally Validated Nomogram for Predicting the Likelihood of Improvement of Clinical Global Impression in Patients With Lifelong Premature Ejaculation …
    738. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of …
    739. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and …
    740. An introduction to psychology for attorneys
    741. An introduction to sexual Medicine
    742. An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses
    743. An investigation of sexual motivation in the female rat
    744. An investigation of the relationship between assertiveness, sex-role values, fantasy, sexual beliefs and sexual satisfaction in females
    745. An investigation of the relationship between physical fitness, self-concept, and sexual functioning
    746. An objective measure of vaginal lubrication in women with and without sexual arousal concerns
    747. An old problem with a new cause-5 alpha reductase inhibitors and persistent sexual dysfunction
    748. An online, mindfulness-based, cognitive-behavioral therapy for female sexual difficulties: impact on relationship functioning
    749. An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer
    750. An open‐label, randomized, flexible‐dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men …
    751. An update on drugs for the treatment of menopausal symptoms
    752. An update on menopause management
    753. An update on sexual function and dysfunction in women
    754. An update on the pharmacological management of female sexual dysfunction
    755. Analysis of a French female sexuality reference population
    756. Analysis of factors that influence the quality of sexual life of climacteric women in China
    757. Analysis of low sexual desire in Chinese women: a national population-based epidemiological survey in mainland China
    758. Analysis Regarding Quality of Life of Menopausal Women on Clinical Disorders during Menopausal Period, on Sukomanunggal Sub-District Surabaya in 2019
    759. Anandamide transforms noncopulating rats into sexually active animals
    760. Anatomic variation and orgasm: Could variations in anatomy explain differences in orgasmic success?
    761. Anatomical study of the obturator foramen and dorsal nerve of the clitoris and their relationship to minimally invasive slings
    762. Anatomy and Physiology of Arousal
    763. Anatomy and physiology of female sexual function and dysfunction
    764. Anatomy and physiology of female sexual function and dysfunction
    765. Anatomy and physiology of genital organs–women
    766. Anatomy and Physiology of the Hypothalamic-Pituitary-Gonadal (HPG) Axis
    767. Anatomy and physiology of women’s sexual function
    768. Anatomy/physiology: Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without Vardenafil on physiological sexual …
    769. ANATOMY/PHYSIOLOGY: Induction of sexual Arousal in Women Under Conditions of Institutional and Ambulatory Laboratory Circumstances: A Comparative Study
    770. Anatomy/physiology: Satisfaction (sexual, life, relationship, and mental health) is associated directly with penile–vaginal intercourse, but inversely with other sexual …
    771. AND DEVIATION
    772. and Erectile Dysfunction
    773. and Long—Term Romantic Partners?
    774. and Mario Maggi